Bausch Health Cos., Inc. (BHC)
Bausch Health Cos. Market Cap : 3.204B for Nov. 19, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 19, 2026 | 3.204B |
| November 18, 2026 | 3.267B |
| November 17, 2026 | 3.170B |
| November 16, 2026 | 3.151B |
| November 13, 2026 | 3.125B |
| November 12, 2026 | 3.088B |
| November 11, 2026 | 3.125B |
| November 10, 2026 | 3.103B |
| November 09, 2026 | 3.144B |
| November 06, 2026 | 3.061B |
| November 05, 2026 | 2.979B |
| November 04, 2026 | 3.121B |
| November 03, 2026 | 3.046B |
| November 02, 2026 | 3.002B |
| October 30, 2026 | 3.069B |
| October 29, 2026 | 3.335B |
| October 28, 2026 | 2.590B |
| October 27, 2026 | 2.362B |
| October 26, 2026 | 2.377B |
| October 23, 2026 | 2.408B |
| October 22, 2026 | 2.427B |
| October 21, 2026 | 2.412B |
| October 20, 2026 | 2.400B |
| October 19, 2026 | 2.363B |
| October 16, 2026 | 2.356B |
| Date | Value |
|---|---|
| October 15, 2026 | 2.359B |
| October 14, 2026 | 2.202B |
| October 13, 2026 | 2.202B |
| October 12, 2026 | 2.217B |
| October 09, 2026 | 2.258B |
| October 08, 2026 | 2.258B |
| October 07, 2026 | 2.299B |
| October 06, 2026 | 2.251B |
| October 05, 2026 | 2.202B |
| October 02, 2026 | 2.169B |
| October 01, 2026 | 2.142B |
| September 30, 2026 | 2.180B |
| September 29, 2026 | 2.169B |
| September 28, 2026 | 2.157B |
| September 25, 2026 | 2.127B |
| September 24, 2026 | 2.113B |
| September 23, 2026 | 2.135B |
| September 22, 2026 | 2.172B |
| September 21, 2026 | 2.109B |
| September 18, 2026 | 2.120B |
| September 17, 2026 | 2.113B |
| September 16, 2026 | 2.127B |
| September 15, 2026 | 2.120B |
| September 14, 2026 | 2.213B |
| September 11, 2026 | 2.191B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| NervGen Pharma Corp. | 206.62M |
| Milestone Pharmaceuticals, Inc. | 49.71M |
| Appili Therapeutics, Inc. | 0.1324M |
| Clearmind Medicine, Inc. | 0.8153M |
| Lexaria Bioscience Corp. | 7.420M |
Market Cap Related Metrics
| PS Ratio | 0.2893 |
| Price to Free Cash Flow | 1.788 |
| Price | 8.56 |
| Earnings Yield | -26.77% |
| Operating PE Ratio | 1.065 |
| Normalized PE Ratio | 8.010 |